ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 117 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $32 | -99.9% | 13,630 | -26.4% | 0.00% | 0.0% |
Q3 2022 | $35,000 | -25.5% | 18,522 | +6.9% | 0.00% | -40.0% |
Q2 2022 | $47,000 | -75.9% | 17,328 | -73.6% | 0.01% | -78.3% |
Q1 2022 | $195,000 | +99.0% | 65,576 | +63.9% | 0.02% | -11.5% |
Q4 2016 | $98,000 | – | 40,017 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |